Mirvetuximab Completed Phase 2 Trials for Folate Receptor Alpha Positive / Estrogen Receptor Negative / Prognostic Stage 2 Breast Cancer AJCC v8 / Anatomic Stage IV Breast Cancer AJCC v8 / Prognostic Stage IIB Breast Cancer AJCC v8 / Anatomic Stage II Breast Cancer AJCC v8 / Progesterone Receptor Negative / Anatomic Stage III Breast Cancer AJCC v8 / HER2 negative / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIA Breast Cancer AJCC v8 / Prognostic Stage IV Breast Cancer AJCC v8 / Triple Negative Breast Carcinoma / Prognostic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIA Breast Cancer AJCC v8 Treatment